🇺🇸 FDA
Pipeline program

INO-5401

GBM-001

Phase 2 mab active

Quick answer

INO-5401 for Glioblastoma is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Glioblastoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials